{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:33Z","timestamp":1792725213258,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejps.2022.106314","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T02:25:56Z","timestamp":1666837556000},"page":"106314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3263-1144","authenticated-orcid":false,"given":"Nan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106314_bib0002","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotin, and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2016","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejps.2022.106314_bib0003","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/jid.2013.399","article-title":"IL-17A RNA aptamer: possible therapeutic potential in some cells, more than we bargained for in others?","volume":"134","author":"Doble","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.ejps.2022.106314_bib0004","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bjd.15533","article-title":"IL-17A and IL-22 producing neutrophils inpsoriatic skin","volume":"177","author":"Dyring-Andersen","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2022.106314_bib0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41419-021-03774-w","article-title":"The endoribonuclease N4BP1 prevents psoriasis by controlling both keratinocyte proliferation and neutrophil infiltration","volume":"12","author":"Gou","year":"2021","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.ejps.2022.106314_bib0006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nature. Communican."},{"key":"10.1016\/j.ejps.2022.106314_bib0007","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/art.30108","article-title":"Therapeutic potential of anti\u2013Interleukin-17A aptamer: Suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models","volume":"63","author":"Ishiguro","year":"2011","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.ejps.2022.106314_bib0008","doi-asserted-by":"crossref","DOI":"10.1080\/10837450.2022.2039943","article-title":"Glycyrrhizic acid assists anti-psoriatic efficacy of a self-deformable curcumin loaded transdermal gel","author":"Jin","year":"2022","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2022.106314_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119101","article-title":"Enhanced penetration and anti-psoriatic efficacy ofcurcumin by improved smartPearls technology with the addition of glycyrrhizic acid","volume":"578","author":"Jin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2022.106314_bib0010","first-page":"345","article-title":"Maximum loaded amorphous azithromycin produced using the wetness impregnation method with fractional steps for dermal prophylaxisagainst Lyme disease","volume":"74","author":"Jin","year":"2019","journal-title":"Pharmazie"},{"issue":"9","key":"10.1016\/j.ejps.2022.106314_bib0011","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jid.2017.04.027","article-title":"Topically delivered tumor necrosis factor-\u03b1 targeted gene regulation for psoriasis","volume":"137","author":"Lewandowski","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106314_bib0012","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jid.2019.06.146","article-title":"Targeting the IL-17 receptor using liposomal spherical nucleic acids as topical therapy for psoriasis","volume":"140","author":"Liu","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejps.2022.106314_bib0013","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fimmu.2019.00857","article-title":"Antimicrobial peptide LL-37 facilitates intracellular uptake of RNA aptamer Apt 21-2 without inducing an inflammatory or interferon response","volume":"10","author":"Macleod","year":"2019","journal-title":"Front. Immunol."},{"issue":"1-2","key":"10.1016\/j.ejps.2022.106314_bib0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijpharm.2018.08.024","article-title":"Dendrimer as a new potential carrier for topical delivery of siRNA: a comparative study of dendriplex vs. lipoplex for delivery of TNF-\u03b1siRNA","volume":"550","author":"Pandia","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2022.106314_bib0015","article-title":"FTIR investigation of the secondary structure of type I collagen: new insight into the amide III band","volume":"229","author":"Stani","year":"2020","journal-title":"Spec. Acta."},{"key":"10.1016\/j.ejps.2022.106314_bib0016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1165\/rcmb.2018-0201OC","article-title":"IL-17A-producing \u03b3\u03b4T cells inhibit the formation of malignant pleural effusions","volume":"61","author":"Wei","year":"2018","journal-title":"Am J Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejps.2022.106314_bib0017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2015.09.017","article-title":"Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges","volume":"219","author":"Zakrewsky","year":"2015","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:03:58Z","timestamp":1760529838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":16,"alternative-id":["S0928098722001993"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106314","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcutaneous amorphous preparation co-delivering curcumin and modified aptamer as a synergistic approach for the amelioration of psoriasis-like skin inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106314"}}